文献速递创伤与烧伤儿科与产科急症

大麻合法化前后儿童创伤患者大麻使用情况

A budding problem: Marijuana use in pediatric trauma patients before and after legalization.
PubMed 文献 · J Trauma Acute Care Surg · 2026-06-05
一句话结论娱乐性大麻合法化后青少年创伤患者THC阳性率从19.5%升至34.4%,暴力致伤比例增加,生理结局未变但心理社会后遗症更常见。

该回顾性队列研究纳入2015至2024年某一级儿童创伤中心12至18岁创伤患者2386例(合法化前1123例,合法化后1263例),比较密歇根州2018年娱乐性大麻合法化前后THC检测率及临床结局。筛查患者中THC阳性率从19.5%升至34.4%(p<0.001),全部创伤患者中从4.6%升至8.7%(p<0.001);暴力致伤机制从27.0%升至36.0%(p<0.001)。合法化后时代(aOR 2.39,95%CI 1.47-3.91)、暴力机制(aOR 2.38,95%CI 1.45-3.91)、年龄较大(aOR 1.21/岁,p=0.002)及酒精共阳性(aOR 10.19,95%CI 2.70-39.57)为THC阳性的独立预测因素。THC阳性青少年更多被转至司法或精神卫生机构(7.0% vs 3.2%,p=0.04),住院时间、手术干预及死亡率相似。

要点

  • 筛查患者中THC阳性率合法化前19.5% vs 合法化后34.4%(p<0.001),全部创伤患者中4.6% vs 8.7%(p<0.001)。
  • 暴力致伤机制占比从合法化前27.0%升至合法化后36.0%(p<0.001),与THC阳性独立相关(aOR 2.38,95%CI 1.45-3.91)。
  • 合法化后时代是THC阳性的独立预测因素(aOR 2.39,95%CI 1.47-3.91),酒精共阳性预测强度最高(aOR 10.19,95%CI 2.70-39.57)。
  • THC阳性青少年出院转至司法或精神卫生机构比例更高(7.0% vs 3.2%,p=0.04),住院时间、手术干预及死亡率无显著差异。
  • 作者建议在儿童创伤系统中实施标准化毒理学筛查和早期物质使用咨询,以增强识别与预防。

适用人群与场景

  • 2015至2024年在某一级儿童创伤中心治疗的12至18岁创伤患者,共2386例(合法化前1123例,合法化后1263例)。

研究设计与关键结果

  • 研究类型为回顾性队列研究,纳入12至18岁创伤患者2386例,比较密歇根州2018年娱乐性大麻合法化前后THC检测及临床结局。
  • 筛查患者中THC阳性率从合法化前19.5%升至合法化后34.4%(p<0.001),全部创伤患者中从4.6%升至8.7%(p<0.001)。
  • 暴力致伤机制从合法化前27.0%升至合法化后36.0%(p<0.001)。
  • THC阳性的独立预测因素包括合法化后时代(aOR 2.39,95%CI 1.47-3.91)、暴力机制(aOR 2.38,95%CI 1.45-3.91)、年龄较大(aOR 1.21/岁,p=0.002)及酒精共阳性(aOR 10.19,95%CI 2.70-39.57)。
  • THC阳性青少年出院转至司法或精神卫生机构比例更高(7.0% vs 3.2%,p=0.04),住院时间、手术干预及死亡率相似。

证据类型、等级与局限

  • 证据类型为回顾性队列研究,证据等级为预后/流行病学Level IV。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在儿童创伤系统中实施标准化毒理学筛查和早期物质使用咨询可能增强识别与预防。
  • 研究显示合法化后青少年创伤患者THC阳性率及暴力致伤比例升高,生理结局未变但心理社会后遗症更常见。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Marijuana legalization may influence adolescent substance use patterns and injury mechanisms, but pediatric data remain limited. Michigan's 2018 legalization of recreational marijuana created a natural setting to evaluate these trends. This study examined changes in marijuana detection and associated clinical outcomes among adolescent trauma patients before and after legalization.

METHODS: We conducted a retrospective cohort study of patients aged 12 to 18 years treated at a Level I pediatric trauma center from 2015 to 2024. Demographics, injury characteristics, toxicology results, and outcomes were compared between prelegalization and postlegalization eras. Urine drug screening and blood alcohol concentration results were reviewed. Multivariable logistic regression identified independent predictors of tetrahydrocannabinol (THC) positivity.

RESULTS: Among 2,386 adolescents (1,123 prelegalization; 1,263 postlegalization), THC positivity increased from 19.5% to 34.4% among screened patients ( p < 0.001) and from 4.6% to 8.7% across all trauma patients ( p < 0.001). Violent mechanisms rose from 27.0% to 36.0% ( p < 0.001). Independent predictors of THC positivity included postlegalization era [adjusted odds ratio (aOR) 2.39, 95% CI: 1.47-3.91], violent mechanism (aOR: 2.38, 95% CI: 1.45-3.91), older age (aOR: 1.21 per year, p = 0.002), and alcohol co-positivity (aOR: 10.19, 95% CI: 2.70-39.57). THC-positive adolescents were more often discharged to justice or psychiatric facilities (7.0% vs. 3.2%, p = 0.04), while length of stay, operative intervention, and mortality were similar.

CONCLUSIONS: Following recreational marijuana legalization, THC detection among adolescent trauma patients increased alongside a higher proportion of violent injuries. Physiologic outcomes remained unchanged, but psychosocial sequelae were more common. Implementing standardized toxicology screening and early substance use counseling within pediatric trauma systems may enhance identification and prevention. ( J Trauma Acute Care Surg. 2026;101: 667-672.).

LEVEL OF EVIDENCE: Prognostic/Epidemiologic; Level IV.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Davis RT, Galvin RM, Oag K, et al. A budding problem: Marijuana use in pediatric trauma patients before and after legalization. J Trauma Acute Care Surg. 2026. PMID: 42246950. doi:10.1097/TA.0000000000004979

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。